Page 45 - Human Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Friday, 12:00, 05/03/2021 VOV.VN - The Institute of Vaccines and Medical Biologicals (IVAC) unveiled on the morning of March 5 that they have begun the process of receiving registrations from volunteers to participate in the initial phase of clinical trials for the second domestically-produced COVID-19 vaccine known as Covivac. During the first phase of human trials, a total of 120 volunteers aged between 18 and 59 will be injected with two 0.5 ml doses of the vaccine 28 days apart. In addition, they will also receive a sum of VND3.6 million in order to cover their travel expenses to t...

Taipei, March 4 (CNA) A controversial claim by transsexual influencer Wangyao (罔腰) that she had become pregnant was "baseless," and the matter will be referred to police for further investigation, Kaohsiung City officials said on Thursday.

An area where volunteers will be monitored after they receive shots at the Hanoi (VNA) – The second phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, will begin on February 26, following the first phase that has been proven safe. As many as 560 volunteers, aged from 18 to 65, will participate in the second phase, according to Nguyen Ngo Quang, Deputy Director of the Department of Science, Technology and Training under the Ministry of Health. The testing will be carried out at the Vietnam Military Medical University in Hanoi and in the Mekong Delta province of Long An b...

February 18, 2021 × The study will help to gain an understanding of how the immune system responds to the virus invasion United Kingdom researchers will soon start the world’s first Covid-19 human trials to study the aftermath of the coronavirus infection on a healthy human immune system, as per media reports. The study will help to gain an understanding of how the immune system responds to the virus invasion. It will further identify factors that influence how it is transmitted, including how a person who is infected “sheds” infectious virus particles into the environment. For the stu...

Thailand's second domestically developed vaccine will soon undergo human trials, officials said on Thursday, adding that the plan was to produce up to five million doses by the end of the year. The vaccine, developed by Thailand's Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said. The announcement comes amid criticism that Thailand's vaccine strategy has been slow and too reliant on AstraZeneca shots being produced by local manufacturer Si...